Läkemedelsbolaget Double Bond Pharma handlas i dag den 27 april exklusive uniträtt i nyemission med företrädesrätt för aktieägarna. En aktie ger tre uniträtter.

Läkemedelsbolaget Double Bond Pharma redovisar som väntat ingen omsättning under andra kvartalet jämfört med samma period året innan. Bolaget

The BeloGal® technology was developed by Double Bond Pharmaceutical and patent filings are in process (PCT/EP2017/025035). Freedom to Operate search in the US and EU determined no comparable drug delivery technologies. All press releases about our company are published by Spotlightstockmarket on their website. You can also download and read our archive news. Teckningskursen i Double Bond International AB (publ):s (”DBP” eller ”Bolaget”) förestående unitemission med företräde för Bolagets aktieägare har fastställts till 1,43 kronor per unit.

Double bond pharmaceutical

Double Bond Pharmaceutical International AB (DBP). Organisationsnummer 556991-6082. Namnändringar och notering på lista. År. Kommentarer. B-aktien är Tagged Double Bond Pharmaceutical framåt » BioStock's article series on MDR and IVDR: Key changes in IVDR » BioStock Studio: DanCann Pharma . Double Bond Pharmaceuticals utvecklar en ny generation av läkemedel inom cancer, infektion och autoimmuna sjukdomar. Teckningsperiod: 15 juni 2015 - 30 19 mar 2020 Uppsala, Sverige och Schiphol, Nederländerna (9 oktober 2019) – Double Bond Pharmaceutical AB (“DBP”) meddelar idag att Specialized Double Bond Pharmaceutical, DBP, är ett läkemedelsbolag.

Double Bond Pharmaceutical AB har idag den 8 maj 2020 överlåtit samtliga av sina 10 000 000 aktier i FarmPharma AB vilket omfattar 74,8

Publicerad: 2020-09-28 (Cision) Double Bond Pharmaceutical, DBP, är ett läkemedelsbolag. Störst inriktning innehas mot behandling av diverse cancersjukdomar, infektioner och autoimmuna sjukdomar. Forskningen utgår ifrån bolagets egenutvecklade drug-delivery teknologi.

Double Bond Pharmaceutical AB We are curious, creative, and have new ideas and ways of working. Above all, we are passionate about science and driven to always put patients first. Join DBP and apply your expertise in a company that are following the science and turn ideas into life changing medicines.

The company is located in Uppsala, Sweden. Double Bond Pharmaceutical International AB is a pharmaceutical company, which engages in developing and commercializing approaches for treatment of cancers, infections, autoimmune diseases, and Double Bond Pharmaceutical is a fast growing pharmaceutical company that develops and commercializes innovative first-in-class approaches for treatment of cancers, infections, autoimmune diseases Double Bond Pharmaceutical International AB is a pharmaceutical company. The company develops and commercializes approaches for the treatment of cancers, infections, autoimmune diseases, and other Double Bond Pharmaceutical International AB is a pharmaceutical company which develops and commercializes approaches for treatment of cancers, infections, autoimmune diseases and other life Double Bond Pharmaceutical International AB is a pharmaceutical company which develops and commercializes approaches for treatment of cancers, infections, autoimmune diseases and other Double Bond Pharmaceutical is a fast growing pharmaceutical company which develops and commercializes innovative first-in-class approaches for treatment of cancers, infections, autoimmune diseases Double Bond Pharmaceutical company which develops and commercialises innovative first-in-class approaches for treatment of cancers, infections, autoimmune diseases and other life-threatening disorders. The main aim of the company is to provide patients and the market with more efficient and safe products in areas where these needs are unmet. Double Bond Pharmaceutical International AB is a pharmaceutical company, which engages in developing and commercializing approaches for treatment of cancers, infections, autoimmune diseases, and Get In Touch Post address: Virdings allé 32B, 75 450 Uppsala, Sweden Visiting address: Rapsgatan 7, Uppsala Business Park (Västra ingången) How Can We Help? Are you interested to know more about our products? Please contact us whatever your need may be and we will be glad to assist you!

Klikkaa tästä ja katso reaaliaikainen osakekurssi Double Bond Pharmaceutical AB We are curious, creative, and have new ideas and ways of working.
Majda baltic

We have developed ways to treat these diseases much more effectively with our drug delivery system. Kjøp Double Bond Pharmaceutical B (DBP B) aksjen. Hos Nordnet kan du handle fra 1 kr i kurtasje. Klikk her for å følge aksjekursen i realtid. Osta osaketta Double Bond Pharmaceutical B (DBP B). Nordnetissä voit käydä kauppaa edullisin hinnoin.

Om jag inte hade aktier utan bara var intresserad av ev aktieköp så hade jag stängt av efter bra några minuter.
Vvs butik falkenberg

Diös Fastigheter, \n, DistIT, \n, Dividend Sweden B, \n, DNB, \n, DNO, \n, DOF, \n, Dome Energy, \n, Dometic Group, \n, Doro, \n, Double Bond Pharmaceutical

Double Bond is a fully integrated healthcare solutions company, helping pharmaceutical stakeholders to Läkemedelsbolaget Double Bond Pharma International meddelar att dotterbolaget Double Bond Pharmaceutical har överlåtit sitt innehav i Farmpharma till moderbolaget.